FDA Inspection
Cipla LimitedCipla Limited – FDA Inspection, Jul 19, 2019
Record Details
This FDA Inspection record concerns Cipla Limited, with an inspection on July 19, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 87069a20-8238-4cd8-bfc5-d14eaee4db66
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1099619
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Cipla Limited
6| Date | Classification | Office | Project area |
|---|---|---|---|
| November 13, 2024 | Not classified | Office of Inspections and Investigations | |
| January 31, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 5, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 25, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 28, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Cipla Limited
- FDA Inspection 1254500 - 2024-11-13
- FDA Inspection 1160347 - 2020-01-31
- FDA Inspection 1009388 - 2017-04-05
- FDA Inspection 891868 - 2014-07-25
- FDA Inspection 790473 - 2012-06-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.